Latest Stem Cell News
Stem Cell Therapy Research for Covid 19 Patients
As we know, Giostar provides personalized protocol treatment for each patient because we continuously produce research that enables us to further comprehend specific considerations for each condition we treat. Covid-19 is also a medical condition which we have had the opportunity of researching, thr...
READ MOREThe Role Of Stem Cell Therapy In Patients With COVID-19
Last Week GIOSTAR had the Opportunity To Participate In the 5th Specialized Course In Regenerative Medicine And Cell Therapy, to Discuss The Role Of Stem Cell Therapy In Patients With COVID-19. The online course was held on Saturday, March 27 and 28. The goal of the program was to cover and review...
READ MOREWe Have Developed A New Protocol For Stem Cell Therapy For Anti-Aging
Our body is filled with millions of cells in charge of every function in our organism and as we grow older, we have fewer active stem cells because of our natural degenerative process. Stem cell therapy focused on anti-aging, takes mesenchymal stem cells and infuses them into the body wher...
READ MOREAn overview of Stem Cell Transplant: Dr. Anand Srivastava
Tijuana, Mexico, February 1st, 2020 Dr. Anand Srivastava, chairman and co-founder of the Global Institute of Stem Cell Therapy and Research (GIOSTAR) assisted to Colegio Mexicano de Células Madre y Medicina Regenerative for the 2nd International Congress of Regenerative Medicine and Cell The...
READ MOREGIOSTAR awaits approval for Type 2 Diabetes Clinical Trial by FDA
We are proud to share the news that GIOSTAR is in the process of approval from the United States of Food and Drug Administration (FDA) to conduct type 2 diabetes clinical trials focused on the development of stem cell treatment. Lead by our Chairman and Co-Founder Dr. Anand Srivastava, a team of sci...
READ MORE